Table 3.
Genomic Alteration | Absolute Numbers | Frequency in % | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
TP53 | 228 | 19.9% | MET | 9 | 0.8% | VA65:C90HL | 4 | 0.3% | RHOA | 2 | 0.2% |
KRAS | 103 | 9.0% | PTCH1 | 9 | 0.8% | CCND1 | 3 | 0.3% | ROS1 | 2 | 0.2% |
PIK3CA | 54 | 4.7% | RAD50 | 9 | 0.8% | CDH1 | 3 | 0.3% | SF3B1 | 2 | 0.2% |
PTEN | 37 | 3.2% | AKT1 | 8 | 0.7% | DDR2 | 3 | 0.3% | SRC | 2 | 0.2% |
APC | 28 | 2.4% | FGFR3 | 8 | 0.7% | ESR1 | 3 | 0.3% | TERT | 2 | 0.2% |
CDKN2A | 28 | 2.4% | SMARCB1 | 8 | 0.7% | FGFR4 | 3 | 0.3% | RHOA | 2 | 0.2% |
NOTCH1 | 26 | 2.3% | BRCA1 | 7 | 0.6% | HRAS | 3 | 0.3% | ROS1 | 2 | 0.2% |
ATM | 25 | 2.2% | IDH2 | 7 | 0.6% | MAP2K1 | 3 | 0.3% | SF3B1 | 2 | 0.2% |
SMAD4 | 19 | 1.7% | MSH6 | 7 | 0.6% | MYCL | 3 | 0.3% | AKT2 | 1 | 0.1% |
IDH1 | 17 | 1.5% | PALB2 | 7 | 0.6% | NTRK1 | 3 | 0.3% | AR | 1 | 0.1% |
PIK3R1 | 17 | 1.5% | SMARCA4 | 7 | 0.6% | PDGFRA | 3 | 0.3% | AXL | 1 | 0.1% |
CTNNB1 | 16 | 1.4% | TSC1 | 7 | 0.6% | RAD51B | 3 | 0.3% | CBL | 1 | 0.1% |
BRCA2 | 15 | 1.3% | ALK | 6 | 0.5% | RNF43 | 3 | 0.3% | CD274 | 1 | 0.1% |
RB1 | 15 | 1.3% | BAP1 | 6 | 0.5% | CDK4 | 2 | 0.2% | CDK4 | 1 | 0.1% |
EGFR | 14 | 1.2% | FGFR2 | 6 | 0.5% | CCND2 | 2 | 0.2% | CHEK2 | 1 | 0.1% |
FANCA | 14 | 1.2% | NBN | 6 | 0.5% | CDK2 | 2 | 0.2% | FANCI | 1 | 0.1% |
POLE | 14 | 1.2% | NF2 | 6 | 0.5% | CHEK1 | 2 | 0.2% | IGF1R | 1 | 0.1% |
TSC2 | 14 | 1.2% | SMO | 6 | 0.5% | ERBB3 | 2 | 0.2% | JAK1 | 1 | 0.1% |
ATR | 13 | 1.1% | CDK12 | 5 | 0.4% | EZH2 | 2 | 0.2% | JAK2 | 1 | 0.1% |
BRAF | 13 | 1.1% | ERBB4 | 5 | 0.4% | FANCD2 | 2 | 0.2% | MAPK1 | 1 | 0.1% |
NF1 | 13 | 1.1% | FGFR1 | 5 | 0.4% | FLT3 | 2 | 0.2% | MCL1 | 1 | 0.1% |
ARID1A | 12 | 1.0% | MLH1 | 5 | 0.4% | GNAQ | 2 | 0.2% | MDM2 | 1 | 0.1% |
CREBBP | 12 | 1.0% | PMS2 | 5 | 0.4% | JAK3 | 2 | 0.2% | MDM4 | 1 | 0.1% |
KIT | 12 | 1.0% | PTPN11 | 5 | 0.4% | MAF | 2 | 0.2% | MSH | 1 | 0.1% |
FBXW7 | 11 | 1.0% | ABL1 | 4 | 0.3% | MAX | 2 | 0.2% | NFE2L2 | 1 | 0.1% |
RET | 11 | 1.0% | ATRX | 4 | 0.3% | MSH2 | 2 | 0.2% | NTRK3 | 1 | 0.1% |
SLX4 | 11 | 1.0% | CCND3 | 4 | 0.3% | mTOR | 2 | 0.2% | PPP2R1A | 1 | 0.1% |
STK11 | 11 | 1.0% | ERBB2 | 4 | 0.3% | MYCN | 2 | 0.2% | RICTOR | 1 | 0.1% |
NOTCH2 | 10 | 0.9% | KDR | 4 | 0.3% | NTRK2 | 2 | 0.2% | TET2 | 1 | 0.1% |
NOTCH3 | 10 | 0.9% | MRE11A | 4 | 0.3% | PDGFRB | 2 | 0.2% | UTR3 | 1 | 0.1% |
SETD2 | 10 | 0.9% | NRAS | 4 | 0.3% | PIK3CB | 2 | 0.2% | AKT2 | 1 | 0.1% |
GNAS | 9 | 0.8% | RAD51D | 4 | 0.3% | RAD51C | 2 | 0.2% |